{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:30:33Z","timestamp":1792452633082,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.gastrohep.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T11:46:45Z","timestamp":1603194405000},"page":"236-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular"],"prefix":"10.1016","volume":"44","author":[{"given":"Paulina","family":"Nu\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Garc\u00eda Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Quera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gomoll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2020.09.002_bib0320","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12891-016-1038-3","article-title":"The challenging interplay between rheumatoid arthritis, ageing and comorbidities","volume":"17","author":"Van Onna","year":"2016","journal-title":"BMC Musculoskelet Disord."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0325","doi-asserted-by":"crossref","DOI":"10.1177\/2050640620950093","article-title":"Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials","author":"Guillo","year":"2020","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0330","article-title":"Extraintestinal Manifestation in patients with inflammatory bowel disease: Study based on the ENEIDA Registry","author":"Algaba","year":"2020","journal-title":"Dig Dis Sci."},{"issue":"Suppl 1","key":"10.1016\/j.gastrohep.2020.09.002_bib0335","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/jcag\/gwy053","article-title":"The impact of Inflammatory bowel disease in Canada 2018: Extra-intestinal diseases in IBD","volume":"2","author":"Bernstein","year":"2019","journal-title":"J Can Assoc Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0340","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/07853890903559724","article-title":"Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management","volume":"42","author":"Larsen","year":"2010","journal-title":"Ann Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0345","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gut.38.5.733","article-title":"Thrombotic vascular risk factors in inflammatory bowel disease","volume":"38","author":"Hudson","year":"1996","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-- an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0355","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0360","doi-asserted-by":"crossref","unstructured":"Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study. Am J Gastroenterol. 2010 Oct;105(10):2195-201.","DOI":"10.1038\/ajg.2010.192"},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0365","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.3748\/wjg.v17.i22.2723","article-title":"Comorbidity in inflammatory bowel disease","volume":"17","author":"San Rom\u00e1n","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0370","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/1381612822666161230142931","article-title":"Inflammation: A novel therapeutic target\/direction in Atherosclerosis","volume":"23","author":"Li","year":"2017","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0375","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.7326\/0003-4819-68-5-1013","article-title":"Thrombocytosis in chronic inflammatory bowel disease","volume":"68","author":"Morowitz","year":"1968","journal-title":"Ann Intern. Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0380","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1572-0241.2004.04129.x","article-title":"Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications","volume":"99","author":"Danese","year":"2004","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0385","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis Find the latest version: Review series Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0390","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3748\/wjg.v8.i3.575","article-title":"Clinical significance of plasma D-dimer and von Willebrand factor levels in patients with ulcer colitis","volume":"8","author":"Xu","year":"2002","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0395","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/BF02208650","article-title":"Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease","volume":"40","author":"Souto","year":"1995","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0400","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fimmu.2018.00430","article-title":"C-reactive protein in Atherothrombosis and Angiogenesis","volume":"9","author":"Badimon","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0405","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.clpt.6100229","article-title":"Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease","volume":"83","author":"Schinzari","year":"2008","journal-title":"Clin Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0410","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2036.2011.04864.x","article-title":"Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases","volume":"34","author":"Oussalah","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jjcc.2012.11.009","article-title":"Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease","volume":"61","author":"Mahalle","year":"2013","journal-title":"J Cardiol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1540-8183.2010.00532.x","article-title":"Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"23","author":"Jensen","year":"2010","journal-title":"J Interv Cardiol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/00365528009181475","article-title":"Endotoxin-induced microclots in ulcerative colitis and Crohn's disease","volume":"15","author":"Juhlin","year":"1980","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0435","article-title":"Inflammatory bowel disease and acute coronary syndromes: from pathogenesis to the fine line between bleeding and ischemic risk","author":"Pepe","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0440","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jss.2011.06.033","article-title":"Toll-like receptor 4 mediates oxidized LDL-induced macrophage differentiation to foam cells","volume":"171","author":"Howell","year":"2011","journal-title":"J Surg Res."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0445","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","article-title":"Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study","volume":"34","author":"Wiedermann","year":"1999","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0450","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","article-title":"Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation","volume":"105","author":"Edfeldt","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0455","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cgh.2005.12.015","article-title":"The impact of increased body mass index on the clinical course of Crohn's disease","volume":"4","author":"Hass","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0460","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","article-title":"The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis","volume":"19","author":"Moran","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0465","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.3748\/wjg.v22.i35.7868","article-title":"Interaction of obesity and inflammatory bowel disease","volume":"22","author":"Harper","year":"2016","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0470","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0475","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ecl.2015.09.002","article-title":"New cholesterol guidelines for the management of atherosclerotic cardiovascular disease risk: a comparison of the 2013 American College of Cardiology\/American Heart Association cholesterol guidelines with the 2014 National Lipid Association recommendation","volume":"45","author":"Adhyaru","year":"2016","journal-title":"Endocrinol Metab Clin."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0485","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/jgh.12260","article-title":"Venous and arterial disease in inflammatory bowel disease","volume":"28","author":"Tan","year":"2013","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0490","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jacl.2010.08.021","article-title":"Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease","volume":"4","author":"Biyyani","year":"2010","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0495","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2036.2008.03886.x","article-title":"Plasma lipids and inflammation in active inflammatory bowel diseases","volume":"29","author":"Romanato","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0500","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/liv.13265","article-title":"Hepatic manifestations of inflammatory bowel diseases","volume":"37","author":"Restellini","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0505","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ibd\/izy200","article-title":"Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: a cohort study using transient elastography","volume":"25","author":"Saroli Palumbo","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0510","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cgh.2007.09.016","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein","year":"2008","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0515","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ibd.21187","article-title":"Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study","volume":"16","author":"Andersohn","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0520","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015","article-title":"Increased risk of acute arterial events in young patients and severely active IBD: A nationwide French cohort study","volume":"67","author":"Kirchgesner","year":"2018","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0525","doi-asserted-by":"crossref","DOI":"10.1111\/apa.15237","article-title":"Cardiovascular risk factors are not present in adolescents with inflammatory bowel disease","author":"Dorfman","year":"2020","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0530","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ajg.2009.81","article-title":"Risk of arterial thrombotic events in inflammatory bowel disease","volume":"104","author":"Ha","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0535","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2013.08.023","article-title":"Risk of cerebrovascular accidents and ischemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0540","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0545","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/gutjnl-2012-303285","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: A nationwide Danish cohort study","volume":"62","author":"Rungoe","year":"2013","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0550","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","article-title":"Venous thrombosis and prothrombotic factors in inflammatory bowel disease","volume":"20","author":"Magro","year":"2014","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0635","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1093\/ibd\/izy157","article-title":"Heart under attack: cardiac manifestations of inflammatory bowel disease","volume":"24","author":"Mitchell","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0640","article-title":"Myocarditis and inflammatory bowel disease. A 16-year Danish nationwide cohort study","volume":"44","author":"S\u00f8rensen","year":"1997","journal-title":"Dan Med Bull."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10620-005-1588-y","article-title":"Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia","volume":"50","author":"Oldenburg","year":"2005","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.crohns.2012.09.005","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations","volume":"7","author":"Van Assche","year":"2013","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0565","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0580","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/ibd.21546","article-title":"Myocarditis associated with infliximab: a case report and review of the literature","volume":"17","author":"Slattery","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0585","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4212\/cjhp.v69i6.1610","article-title":"5-Aminosalicylic acid-associated myocarditis and pericarditis: a narrative review","volume":"69","author":"Brown","year":"2016","journal-title":"Can J Hosp Pharm."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0645","doi-asserted-by":"crossref","unstructured":"Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003 Dec 16;108(24):3006-10.","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0590","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/europace\/eut312","article-title":"Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study","volume":"16","author":"Kristensen","year":"2014","journal-title":"Europace."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0595","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3748\/wjg.v25.i22.2788","article-title":"Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population- base study","volume":"25","author":"Choi","year":"2019","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0600","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1076029616632906","article-title":"Etiopathogenesis Prevention, and Treatment of Thromboembolism in Inflammatory Bowel Disease","volume":"23","author":"Alkim","year":"2017","journal-title":"Clin App Thromb Hemost."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0610","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejim.2012.12.015","article-title":"Heart failure and anti tumor necrosis factor-alpha in systemic chronic inflammatory diseases","volume":"24","author":"Sinagra","year":"2013","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0615","doi-asserted-by":"crossref","first-page":"e0225572","DOI":"10.1371\/journal.pone.0225572","article-title":"Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system","volume":"14","author":"Cross","year":"2019","journal-title":"PLoS One."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0620","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2019.04.059","article-title":"Tofacitinib treatment is associated with modest and reversible increases in serum lipids in patients with Ulcerative Colitis","volume":"18","author":"Sand","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0625","article-title":"Farmacolog\u00eda y seguridad de tofacitinib en colitis ulcerosa","volume":"S0210\u20135705","author":"L\u00f3pez-Sanrom\u00e1n","year":"2020","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2020.09.002_bib0630","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/apt.15514","article-title":"Venous thromboembolic events in the tofacitinib Ulcerative Colitis clinical development programme","volume":"50","author":"Sandborn","year":"2019","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570520303757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570520303757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:43:47Z","timestamp":1759322627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570520303757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0210570520303757"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2020.09.002","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La enfermedad inflamatoria intestinal y los riesgos de enfermedad cardiovascular","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}